×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Taro
Taro
Ads
Taro shareholders approve merger with Sun Pharma
Sun Pharma to acquire remaining 21.52% shares of Taro for Rs 2,892 crore
Sun Pharma: Premium valuation caps upside
Sun Pharma: Stretched valuation a sticking point, what else to watch out for?
Sun Pharma: Traction in specialty impressive
Analysts consensus is bearish on pharma stocks – should one buy?
Have buy calls on Cadila, Aurobindo Pharma & Lupin: HDFC Securities
Sun Pharma, Wockhardt in news on re-inspections, lawsuits
Sun Pharma Q2 profit seen up 52%, US sales may drive revenue
Sun Pharma falls 7%, sector under pressure on US probe fear
Analysts bet psoriasis drug to aid Sun Pharma's US kitty
Sun Pharma to acquire InSite Vision; stock gains 2.3%
Sun Pharma up on Taro's Keveyis launch, $100mn sales seen
Sun Pharma up 5%; BoAML upgrades to buy, weak rupee to aid
Sun Pharma up 3%, raises Ranbaxy's products prices in US
Ranbaxy effect playing on Sun Pharma's margins: Pros
Sun Pharma, Ranbaxy up 2.5% on new leadership team
Ranbaxy merger: Sun Pharma readies new leadership team
European Union lifts ban on import of mangoes from India
Sun Pharma maintains 13-15% FY15 topline guidance: CFO
2014: Blockbuster year for Sun Pharma's Dilip Shanghvi
Merger with Ranbaxy might get delayed: Sun CFO Baldota
Experts disappointed with Sun Pharma Q2 nos but not bearish
Taro Q2 results boost Sun Pharma, stock hits record high
Sun Pharma jumps 2% post Q3 nos, gets FDA nod for Temodar
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio